Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Adverum Biotechnologies Inc. buy Chardan Capital

Adverum Biotechnologies Inc.
Start price
€1.38
13.08.25 / 50%
Target price
€28.26
13.08.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 13.08.26. The prediction end date can be changed by Chardan_Capital at any time.
Performance without dividends (%)
Name 1w 1m
Adverum Biotechnologies Inc. - -
iShares Core DAX® 1.803% 0.496%
iShares Nasdaq 100 0.429% -0.410%
iShares Nikkei 225® 0.708% -3.799%
iShares S&P 500 0.288% -0.218%

Comments by Chardan_Capital for this prediction

In the thread Adverum Biotechnologies Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 28.261
Change
Ends at 13.08.26

Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $33.00 price target on the stock.
Ratings data for ADVM provided by MarketBeat

Chardan Capital 
0
Report Share
13.08.25

Stopped prediction by Chardan_Capital for Adverum Biotechnologies Inc.

buy
Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€1.38
15.05.25
€29.48
15.05.26
-
20.03.24

Chardan Capital 
15.05.25 50%
buy
Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€1.38
17.04.25
€29.04
17.04.26
-
20.03.24

Chardan Capital 
17.04.25 50%
buy
Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€1.38
19.07.24
€36.70
19.07.25
-
20.07.25

Chardan Capital 
19.07.24 50%
buy
Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€1.51
19.03.24
€3.68
19.03.25
-8.61%
20.03.25

Chardan Capital 
19.03.24 50%